Neuland Q1 net profit jumps 10x to Rs 148 cr, revenue doubles; Rs 40 cr guarantee to Gland Pharma

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionContingent Liabilities IncreasedResults View source PDF Explain this filing

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+7.9%Reaction day

₹20023.00

prior close

₹21800.00

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.2%+7.7% vs market

Pharmaceuticals peers, median of 167sector-0.2%+8.1% vs sector

On the reaction day the stock moved 7.7 pts more than Nifty Smallcap 250 and 8.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.2

10m

-2.8

15m

-2.0

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+7.9+0.2+7.7-0.2+8.1

Next day

+14.4+0.2+14.3+0.3+14.1

+11.1+0.1+11.0+0.6+10.5

+14.8+0.3+14.5+0.6+14.2

+12.4+0.1+12.3+0.5+11.9

+15.4+0.2+15.1+0.9+14.5

+18.1-0.1+18.2-0.2+18.3

15d

+17.0+0.6+16.4-0.2+17.2

+14.6+0.9+13.7+2.3+12.3

+9.6-2.3+11.9+2.4+7.2

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Neuland Labs Q1 FY26 consolidated revenue jumped 119% YoY to Rs 641.58 cr from Rs 292.75 cr. Net profit surged over 10x to Rs 147.67 cr from Rs 13.90 cr. EPS stood at Rs 115.10. Board also approved a Rs 40 cr corporate guarantee for Gland Pharma under a loan licence for sterile API manufacturing, and Rs 39.8 cr capex to add 18 KL capacity at Bonthapally unit funded by internal accruals.

Likely market impact

Blockbuster quarter with revenue doubling and profit growing 10x signals strong momentum. Rs 40 cr guarantee to Gland Pharma is a contingent liability; capex supports growth.